St. Anthony is pleased to announce the opening of St. Anthony Urgent Care. The new facility is located at St. Anthony North, at the corner of Broadway Extension and N.W. 63rd street.
Under medical director Dr. Chad Borin, providers Kristi McKee, PA-C and Nicole Miller, PA-C, will offer compassionate care for minor illnesses and injuries. St. Anthony Urgent Care is available for non-emergency illnesses such as colds, flu, and sinus infections, as well as minor injuries. Patients visiting the clinic will benefit with fast treatment, an electronic health record, an onsite lab and X-Ray, as well as quick access to specialists.
Open every day from 8 a.m. to 8 p.m., St. Anthony Urgent Care offers convenient hours for those inconvenient moments in our lives.

INTEGRIS Health Edmond is named one of America’s Best Hospitals for Emergency Care by the Women’s Choice Award. This coveted credential places INTEGRIS Health Edmond in the top one percent for emergency care.
“The Women’s Choice Award seal delivers a powerful message to the women of Edmond and surrounding areas,” says hospital president Avilla Williams. “It offers them reassurance and peace of mind that INTEGRIS Health Edmond is clinically excellent and prepared to care for and treat their families when they need it most.”
Emergency services account for more than 125 million hospital visits annually, and all clinicians must have expertise in caring for patients across their life span, often when their health care needs are urgent and unplanned. Unlike other hospital departments that interact with the same patient and families for an extended period, emergency staffs typically have one patient encounter, often when anxiety and fear is at its peak.
Hospitals earning the Emergency Care Award consistently rank in the top 25 percent of the 3,800 hospitals reporting on their emergency department’s performance to the Centers for Medicare and Medicaid Services. The eight measures CMS publicly reports relate primarily to the amount of time taken in the ER such as time for diagnosis, medication, and admission to the hospital, and are weighted according to the priorities of women surveyed.
“We have found that recommendations are an important consideration used by women in selecting a hospital for themselves and their family. By helping women know which hospitals in their area provide the best critical care, we are able to help them make better decisions, especially when it comes to emergency situations,” said Delia Passi, chief executive officer and founder of the Women’s Choice Award.
Year after year, the Women’s Choice Award is the only credential that identifies the nation’s best health care institutions by measuring against the needs and preferences of women, when it comes to treatment and a quality hospital experience. This credential signifies INTEGRIS’ commitment and passion towards an extraordinary health care experience for women and all patients.

Per the Journal of the American Medical Association, hearing loss is one of the most common chronic health conditions and has important implications for a person’s quality of life. However, hearing loss is substantially undetected and untreated.
At INTEGRIS Health we believe everyone age 55 and older should have their hearing checked every year as part of their overall wellness.
In recognition of National Speech and Hearing Month, the INTEGRIS Cochlear Implant Clinic will offer complimentary hearing screenings for individuals who have not yet been diagnosed with a hearing loss. If you currently wear a hearing aid or have been diagnosed with a hearing loss, a screening will not be sufficient.
The doctors of audiology at the INTEGRIS Cochlear Implant Clinic can help determine if you have a hearing loss and what treatment options they can offer you. The screenings are available by appointment only.
For more information or to schedule an appointment for a complimentary hearing screening, please call the INTEGRIS Cochlear Implant Clinic 405-947-6030.

New recommendations aim to prevent ovarian cancer

Saving women from an often silent killer is at the heart of new recommendations for ovarian cancer prevention from a top researcher and clinician at the Stephenson Cancer Center at the University of Oklahoma as well as counterparts nationwide.
It’s estimated that almost 22,000 women in this country will learn they have ovarian cancer this year alone, and more than 14,000 women will die of the disease. The disease often is not detected until it is in an advanced stage because there seldom are symptoms until it has already spread. Since early detection through screening and symptom detection has failed to reduce mortality, top cancer researchers and clinicians nationwide now have issued a list of recommendations aimed at stopping the cancer before it starts.
Joan Walker, M.D., gynecologic oncologist with the Stephenson Cancer Center at the University of Oklahoma Health Sciences Center, is lead author on the commentary published in Cancer. Walker also holds the George Lynn Cross Research Professorship in Gynecology and Oncology with the OU College of Medicine.
“These new recommendations are aimed at helping save lives,” Walker said. “ Recent scientific breakthroughs have provided new insights into ovarian cancer? how it forms, how it spreads and who is at greatest risk. With that knowledge, we felt it was important to make a strong recommendation to both the public and health care providers about how to best prevent ovarian cancer.”
The new recommendations include the use of oral contraceptives and instead of tubal sterilization, they recommend the removal of the fallopian tubes. For women at high hereditary or genetic risk of breast and ovarian cancer, risk-reducing removal of the fallopian tubes and ovaries is recommended. Finally, they recommend genetic counseling and testing for women with ovarian cancer and other high-risk family members. Women identified with excess risk of ovarian cancer can reduce that risk to almost zero with the removal of the fallopian tubes and ovaries, but they experience premature menopause.
“For women with an average risk of developing ovarian cancer, we know that the use of oral contraceptives can cut their lifetime risk for ovarian cancer by 40 to 50 percent. The longer oral contraceptives are used, the greater the benefit and that benefit can last up to 15 years after a woman has stopped using oral contraceptives,” Walker said.
Tubal ligation, a procedure in which a woman’s fallopian tubes are blocked, tied or cut, has been associated with a 34 percent reduction in the risk of ovarian cancer in women at average risk for ovarian cancer. With the new scientific evidence, the authors indicated they prefer the removal of the fallopian tubes as a preventive measure.
“Studies have reported a 70 to 85 percent reduction in ovarian cancer as well as a 37 to 54 percent reduction in breast cancer in women at high hereditary risk with the removal of both the ovaries and fallopian tubes,” Walker said. “Growing evidence shows that most type 2 ovarian cancers develop as a result of cellular changes in cells within the fallopian tubes.”

“This information is especially important for women at increased risk for breast and ovarian cancer. These recommendations are intended to help encourage an open discussion between women and their health care providers,” Walker said.